Dernières nouvelles pour Lonza Group (OTC:LZAGF) Stock

Lonza Group is a contract development and manufacturing organization, or CDMO. It operates under four segments: small molecules, biologics, cell & gene, and capsules & health ingredients. Lonza derives its revenue primarily from long-term supply agreements with pharmaceutical customers. The company provides a range of development and manufacturing services throughout the entire lifecycle of a product from drug research to commercial supply. The majority of Lonza's customers are pharmaceutical and biotechnology companies, academic institutions, and government research organizations.

Comments

Lonza Group

Actualités

Dernières nouvelles pour Lonza Group (OTC:LZAGF) Stock

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL